Company Sernova Toronto S.E.

Stocks

SVA

CA81732W1041

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. Other stock markets 14:45:05 2026-07-31 EDT			5-day change	1st Jan Change
0.1100 ^CAD	-.--%		-.--%	-15.38%

06-17	Sernova's Autologous Islet Transplantation Gets Orphan Drug Designation For Type 3c Diabetes Prevention	MT
06-11	Sernova Biotherapeutics Inc Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI

Business description: Sernova

Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.

Sales by Activity: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all business segments

Geographical breakdown of sales: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all geographic segments

Executive Committee: Sernova

Manager	Title	Age	Since
Jonathan Rigby CEO	Chief Executive Officer	58	2024-08-11
James Parsons DFI	Director of Finance/CFO	60	2024-10-10
David Burke IRC	Investor Relations Contact	-	2024-10-10
Marie Kaldchibachi PRN	Corporate Officer/Principal	-	-
Gary Floyd SEC	Corporate Secretary	-	-

See SERNOVA governance

Composition of the Board of Directors: Sernova

Director	Title	Age	Since
James Parsons BRD	Director/Board Member	60	2012-04-18
Steven Sangha BRD	Director/Board Member	-	2023-04-23
David Paterson BRD	Director/Board Member	-	2024-08-31
Bernd Mühlenweg BRD	Director/Board Member	54	2024-03-31
Tanya Lewis BRD	Director/Board Member	55	-
John Brooks CHM	Chairman	75	2025-09-22

Composition of the Board of Directors

Shareholders: Sernova

Name	Stocks	%	Valuation
Steven Sangha 13.16 %	49,703,667	13.16 %	5 M $
James Parsons 0.1627 %	614,605	0.1627 %	61 461 $
Jonathan Rigby 0.0609 %	229,877	0.0609 %	22 988 $
CATAM Asset Management AG 0.0397 %	150,000	0.0397 %	15 000 $
Modestus Obochi 0.0132 %	50,000	0.0132 %	5 000 $

List of SERNOVA shareholders

Company details: Sernova

Sernova Biotherapeutics, Inc.

700 Collip Circle

N6G 4X8, London

+917-751-5713

http://www.sernova.com

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STRYKER CORPORATION	+4.76%	+1.32%	-9.69%	+23.79%	125B
SMITH & NEPHEW PLC	+3.32%	+3.01%	+3.50%	+6.49%	13.12B
GLAUKOS CORPORATION	+2.49%	+12.48%	+98.32%	+129.57%	9.83B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-2.80%	+1.43%	-42.58%	-66.81%	4.86B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.16%	-3.89%	-4.43%	+33.02%	2.61B
ENOVIS CORPORATION	+7.79%	+11.22%	+22.07%	-46.71%	1.68B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+1.81%	+7.80%	-23.47%	-29.31%	1.68B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.48%	+5.51%	-14.40%	-19.19%	1.67B
Average	+2.09%	+4.48%	+3.66%	+3.86%	20.05B
Weighted average by Cap.	+4.13%	+2.23%	-2.76%	+24.52%